Literature DB >> 22233946

Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity.

Robert J Walter1, Bashar M Attar, Asad Rafiq, Sooraj Tejaswi, Megan Delimata.   

Abstract

CONTEXT: Pancreatic cancer is highly resistant to treatment. Previously, we showed that Newcastle disease virus (NDV) strain 73-T was highly cytotoxic to a range of tumor types in vitro and in vivo but the effects of NDV on pancreatic tumors are unknown. We determined the cytotoxicity of the lentogenic LaSota strain of NDV (NDV-LS) toward 7 different human pancreatic tumor cell lines and 4 normal human cell lines (keratinocytes, fibroblasts, pancreatic ductal cells, and vascular endothelial cells).
METHODS: Cytotoxicity assays used serially diluted NDV incubated for 96 hours post-infection. Cells were fixed, stained, and minimum cytotoxic plaque forming unit (PFU) doses were determined (n = 10-24/cell line).
RESULTS: Normal cells were killed only by high doses of NDV-LS. The cytotoxic doses for pancreatic ductal cells, fibroblasts, and vascular endothelial cells were 729, 626, and 1,217 plaque forming units, respectively. In contrast, most pancreatic cancer cells were killed by much lower doses. The doses for PL45, Panc 10.05, PANC-1, BxPC3, SU.86.86, Capan-1 and CFPAC-1 were 0.15, 0.41, 0.43, 0.55, 1.30, 17.1 and 153 plaque forming units, respectively.
CONCLUSIONS: Most pancreatic tumor cells were more than 700 times more sensitive to NDV-LS killing than normal cells. Such avirulent, lentogenic NDV strains may have therapeutic potential in the treatment of pancreatic cancers.

Entities:  

Mesh:

Year:  2012        PMID: 22233946

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  9 in total

1.  Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection.

Authors:  P R A Buijs; C H J van Eijck; L J Hofland; R A M Fouchier; B G van den Hoogen
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

2.  Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo.

Authors:  Syed Umar Faruq Syed Najmuddin; Zahiah Mohamed Amin; Sheau Wei Tan; Swee Keong Yeap; Jeevanathan Kalyanasundram; Muhamad Alhapis Che Ani; Abhimanyu Veerakumarasivam; Soon Choy Chan; Suet Lin Chia; Khatijah Yusoff; Noorjahan Banu Alitheen
Journal:  Cancer Cell Int       Date:  2020-06-29       Impact factor: 5.722

3.  Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.

Authors:  Kseniya S Yurchenko; Peipei Zhou; Anna V Kovner; Evgenii L Zavjalov; Lidiya V Shestopalova; Alexander M Shestopalov
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

4.  In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells.

Authors:  Ahmed M Al-Shammari; Marwa I Salman; Yahya D Saihood; Nahi Y Yaseen; Khansaa Raed; Hiba Kareem Shaker; Aesar Ahmed; Aseel Khalid; Ahlam Duiach
Journal:  Biomedicines       Date:  2016-01-29

5.  Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma.

Authors:  Diana Sánchez; Rosana Pelayo; Luis Alberto Medina; Eduardo Vadillo; Rogelio Sánchez; Luis Núñez; Gabriela Cesarman-Maus; Rosa Elena Sarmiento-Silva
Journal:  Viruses       Date:  2015-12-23       Impact factor: 5.048

Review 6.  Oncolytic virotherapy in upper gastrointestinal tract cancers.

Authors:  Raquel Yokoda; Bolni M Nagalo; Mansi Arora; Jan B Egan; James M Bogenberger; Thomas T DeLeon; Yumei Zhou; Daniel H Ahn; Mitesh J Borad
Journal:  Oncolytic Virother       Date:  2018-03-23

7.  Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.

Authors:  Mohsen Keshavarz; Mir Saeed Ebrahimzadeh; Seyed Mohammad Miri; Hassan Dianat-Moghadam; Seyedeh Sara Ghorbanhosseini; Seyed Reza Mohebbi; Hossein Keyvani; Amir Ghaemi
Journal:  Virol J       Date:  2020-05-05       Impact factor: 4.099

Review 8.  Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.

Authors:  Molly C Holbrook; Dakota W Goad; Valery Z Grdzelishvili
Journal:  Cancers (Basel)       Date:  2021-03-09       Impact factor: 6.639

Review 9.  Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.

Authors:  Bartosz Kamil Sobocki; Karolina Kaźmierczak-Siedlecka; Marcin Folwarski; Viktoria Hawryłkowicz; Wojciech Makarewicz; Ewa Stachowska
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.